Thrombosis with thrombocytopenia syndrome’ (TTS) is a newly described serious condition that features unusual blood clots in the brain or other parts of the body. A very rare condition that has been linked to the AstraZeneca COVID vaccine, TTS is associated with low platelet levels and can cause serious long-term disability or death.
Leading haematologists Dr Danny Hsu and Dr Vivien Chen will provide a review of Australian cases of TTS, discuss the newly released guidelines, and look at how to address patient concerns.
- Discuss the clinical features of the rare complication of Thrombosis and Thrombocytopenia Syndrome post-AstraZeneca vaccination.
- Describe the pathophysiology of Thrombosis and Thrombocytopenia Syndrome.
- Be aware of the incidence of Thrombosis and Thrombocytopenia Syndrome
This event attracts 2 CPD points
A/Prof Charlotte Hespe
Chair, RACGP NSW&ACT
Charlotte Hespe works part time in clinical General Practice in Inner City Glebe as a Principal of a 16 Dr Group Practice. She also works as Head of General Practice and Primary Care Research for University of Notre Dame, Australia, School of Medicine, Sydney. She is actively involved with the RACGP, and is current chair RACGP NSW/ACT Faculty Council and a Director on the RACGP Board.
Dr Ai-Vee Chua
General Practitioner, Dubbo Family Doctors
In her role as a clinician, Dr Ai-Vee Chua enjoys all aspects of general practice, and has particular interests in general medicine, children's health, and women's health. She is a strong proponent of preventive health, and is committed to a patient-centered approach to healthcare.
Dr Vivien Chen
Dr Danny Hsu
Senior Staff Specialist (Haematology)